Down-regulation of MKP-1 in hippocampus protects against stress-induced depression-like behaviors and neuroinflammation

• Published in: Translational psychiatry 2024-03, Vol.14 (1), p.130-130, Article 130
• Main Authors: Geng, Mengjun, Shao, Qiujing, Fu, Jiacheng, Gu, Jingyang, Feng, Laipeng, Zhao, Liqin, Liu, Cong, Mu, Junlin, Zhang, Xiaoli, Zhao, Mingjun, Guo, Xinsheng, Song, Cai, Li, Yan, Wang, Huiying, Wang, Changhong
• Format: Article
• Language: English
• Subjects: 13/1; 13/21; 13/51; 13/89; 14/28; 14/32; 14/34; 14/35; 14/5; 38/22; 38/23; 38/35; 38/77; 45/29; 631/378/340; 692/420/2489; 692/699/476/1414; 82/1; 82/80; Behavioral Sciences; Biological Psychology; Kinases; Medicine; Medicine & Public Health; Mental depression; Neurosciences; Pharmacotherapy; Phosphorylation; Psychiatry; Tumor necrosis factor-TNF
• ISSN: 2158-3188; 2158-3188
• DOI: 10.1038/s41398-024-02846-7

Chronic stress is the primary environmental risk factor for major depressive disorder (MDD), and there is compelling evidence that neuroinflammation is the major pathomechanism linking chronic stress to MDD. Mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) is a negative regulator of MAPK signaling pathways involved in cellular stress responses, survival, and neuroinflammation. We examined the possible contributions of MKP-1 to stress-induced MDD by comparing depression-like behaviors (anhedonia, motor retardation, behavioral despair), neuroinflammatory marker expression, and MAPK signaling pathways among rats exposed to chronic unpredictable mild stress (CUMS), overexpressing MKP-1 in the hippocampus, and CUMS-exposed rats underexpressing MKP-1 in the hippocampus. Rats exposed to CUMS exhibited MKP-1 overexpression, greater numbers of activated microglia, and enhanced expressions of neuroinflammatory markers (interleukin [IL]-6, [IL]-1β, tumor necrosis factor [TNF]-ɑ, and decreased phosphorylation levels of ERK and p38 in the hippocampus as well as anhedonia in the sucrose preference test, motor retardation in the open field, and greater immobility (despair) in the forced swimming tests. These signs of neuroinflammation and depression-like behaviors and phosphorylation levels of ERK and p38 were also observed in rats overexpressing MKP-1 without CUMS exposure, while CUMS-induced neuroinflammation, microglial activation, phosphorylation levels of ERK and p38, and depression-like behaviors were significantly reversed by MKP-1 knockdown. Moreover, MKP-1 knockdown promoted the activation of the MAPK isoform ERK, implying that the antidepressant-like effects of MKP-1 knockdown may be mediated by the ERK pathway disinhibition. These findings suggested that hippocampal MKP-1 is an essential regulator of stress-induced neuroinflammation and a promising target for antidepressant development.